These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5447911)

  • 1. [Experience in the use of bifidumbacterin in children with prolonged intestinal diseases].
    Zatsepin IuK; D'iakova EI; Goncharova GI; Liannaia AM; Kozlova EP; Aleksandrova AM; Kozhevitskaia OB
    Pediatriia; 1970 May; 49(5):62-4. PubMed ID: 5447911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 3. [The fermented milk product biofruktolakt in the treatment of children with intestinal dysfunctions of various etiologies].
    Feklisova LV; Novokshonova VA; Nekrasova TV; Lagoda IV; Ladodo KS
    Pediatriia; 1988; (6):75-7. PubMed ID: 3186411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of colibacterin in children with dysentery and in some other intestinal infections].
    Riabinskaia TF; Kanshina OA; D'iakova EI; Koroleva AI
    Vopr Okhr Materin Det; 1967 Jun; 12(7):89-90. PubMed ID: 4887098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections].
    Korviakova EP
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colibacterin in intestinal diseases associated with dysbacteriosis].
    Pospelova VV; D'iakova EI; Vil'shanskaia FL
    Klin Med (Mosk); 1970 May; 48(5):59-61. PubMed ID: 4915001
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of bifidumbacterin and complex therapy of prolonged intestinal dysfunction in young children].
    Aleksandrova AM; Zatsepin IuK; Goncharova GI
    Vopr Okhr Materin Det; 1970 Nov; 15(11):40-3. PubMed ID: 5532748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
    Chernysheva NA; Mel'nikova KI; Finkel' MP; Izotova ZB
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):37-9. PubMed ID: 8017124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What have biological drugs changed in inflammatory rheumatic, skin and bowel diseases?].
    Hannonen P; Rantanen T; Jussila A
    Duodecim; 2016; 132(4):357-64. PubMed ID: 27017788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The possibilities for correcting the dysbacteriosis occurring in the prolonged external diversion of bile].
    Shor-Chudnovskiĭ ME; Susak IaM; Grigor'ev AV; Kurik MV; Shelkovaia NG
    Klin Khir (1962); 1993; (11):30-2. PubMed ID: 8207906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of using bifidokefir for the treatment of acute intestinal infections and for the correction of dysbacterosis in children].
    Murashova AO; Novokshonov AA; Uchaĭkin VF
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):108-10. PubMed ID: 7879497
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment efficacy in acute intestinal infections, chronic diseases of the gastrointestinal tract and viral hepatitis B using large doses of Russian Bifidumbacterin-forte].
    Gracheva NM; Shcherbakov IT; Avakov AA; Matsulevich TV
    Voen Med Zh; 1999 May; 320(5):51-7, 96. PubMed ID: 10401251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis].
    Liz'ko NN; Goncharova GI
    Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of bifidumbacterin for prevention of staphylococcal infections in newborn infants].
    Astakhov II
    Vopr Okhr Materin Det; 1978 Jan; 23(1):75-7. PubMed ID: 625915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of various diseases complicated by dysbacteriosis of the intestines].
    Krasnogolovets VN
    Klin Med (Mosk); 1970 May; 48(5):54-9. PubMed ID: 4915000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.